Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! In an aim to expand their product portfolio, the company is focusing on developing multiple manufacturing sites Bhavya Rathod / Monday, January 30, 2023 / Article rating: 3.7 They initiated contract manufacturing from three new locations this quarter and with this, they are currently manufacturing at nine locations across India
Multibagger Update: Fredun Pharmaceuticals locks at 5 per cent upper circuit; here's why! Multibagger Update: Fredun Pharmaceuticals locks at 5 per cent upper circuit; here's why! The pharma company announced the final dividend at 7 per cent per equity share, having a face value of Rs 10 each for the financial year 2021-22. Mandar Wagh / Tuesday, May 17, 2022 / Article rating: 4.7 The net profit of Fredun Pharmaceuticals soared 214.34 per cent to Rs 6.33 crore.
Multibagger Update: Fredun Pharmaceuticals rallies 10 per cent; records fresh 52-week high! Multibagger Update: Fredun Pharmaceuticals rallies 10 per cent; records fresh 52-week high! The company had recently conducted a grand launch for ‘Freossi’ range of products in Mumbai in association with PPAM Armaan Madhani / Thursday, April 21, 2022 / Article rating: 4.3 Shares of Fredun Pharmaceuticals have more than doubled in less than six months.
Multibagger Alert: Fredun Pharmaceuticals jumps 3.40 per cent; receives approval to manufacture Xenografts from CDSCO Multibagger Alert: Fredun Pharmaceuticals jumps 3.40 per cent; receives approval to manufacture Xenografts from CDSCO The stock has furnished returns of 11 per cent over the last five trading sessions. Armaan Madhani / Monday, March 14, 2022 / Article rating: 4.3 The stock has furnished returns of 11 per cent over the last five trading sessions.
Multibagger Alert: Fredun Pharmaceuticals jumps 12 per cent in two days post Q3 results; hits fresh 52-week high Multibagger Alert: Fredun Pharmaceuticals jumps 12 per cent in two days post Q3 results; hits fresh 52-week high Over Q3FY22, the company has commissioned a state of the art warehousing facility totalling 60,000 sq. ft. capacity. Armaan Madhani / Monday, January 31, 2022 / Article rating: 4.5 The stock has gained 30.78 per cent and 163.28 per cent over the past one and six months, respectively.